TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33104504

Group type: EXPERIMENTAL
Intervention: Preferred ankle angle during ramp ascent
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Preferred ankle angle during ramp descent
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Response rate to preferred alignment during level-ground walking
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Socket pressures and tibial progression during ramp walking
Number of subjects: 7
Study: 33010934

Group type: EXPERIMENTAL
Intervention: 0.125 mg of palonosetron (Group 1)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 4 mg of ondansetron associated with 4 mg of dexamethasone (Group 2)
Number of subjects: 60

Group type: COMPARATOR
Intervention: 4 mg of dexamethasone (Group 3)
Number of subjects: 60
Study: 35442963

Group type: EXPERIMENTAL
Intervention: ACT intervention
Number of subjects: 98

Group type: COMPARATOR
Intervention: Waiting list control group
Number of subjects: 98
Study: 34509736

Group type: EXPERIMENTAL
Intervention: Unplugged program
Number of subjects: 2685

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 2685
Study: 32507057

Group type: EXPERIMENTAL
Intervention: Spinomed orthosis
Number of subjects: 44
Study: 36443585

Group type: EXPERIMENTAL
Intervention: Phloroglucinol (oral or IV/IM)
Number of subjects: 364

Group type: COMPARATOR
Intervention: Reference drug (dexketoprofen for urinary spasms and pain; metamizole or scopolamine for biliary colic)
Number of subjects: 364
Study: 32844557

Group type: EXPERIMENTAL
Intervention: Dapagliflozin
Number of subjects: 17200

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17200
Study: 32147654

Group type: EXPERIMENTAL
Intervention: Lifestyle intervention using mobile technology plus usual care
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care alone
Number of subjects: 0
Study: 35770295

Group type: EXPERIMENTAL
Intervention: CCRT with docetaxel plus cisplatin (DP)
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: CCRT with docetaxel (D)
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: CCRT with cisplatin (P)
Number of subjects: 125
Study: 34154666

Group type: EXPERIMENTAL
Intervention: Standard EMOTION intervention delivered in 16 group-based sessions
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Partially-digital EMOTION intervention delivered as eight group sessions and eight digital sessions
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: High involvement with parent participation in a 5-session parent group
Number of subjects: 40

Group type: COMPARATOR
Intervention: Low involvement sharing information with parents via a brochure
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Measurement and feedback system (MFS) for group leaders
Number of subjects: 40

Group type: COMPARATOR
Intervention: No measurement and feedback system (no MFS)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Self-report questionnaires pre-, post-, and one year after intervention
Number of subjects: 40
Study: 36484189

Group type: EXPERIMENTAL
Intervention: Dynamic qi acupuncture with needle retention for 10 min (observation group A)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Dynamic qi acupuncture with needle retention for 20 min (observation group B)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Dynamic qi acupuncture with needle retention for 30 min (observation group C)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Celecoxib capsules, 0.2 g twice a day (medication group)
Number of subjects: 160
Study: 34287900

Group type: EXPERIMENTAL
Intervention: ERAS protocol
Number of subjects: 38

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 38
Study: 33009349

Group type: EXPERIMENTAL
Intervention: Magnesium supplementation (350 mg·d ‐1 , 10 days)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Magnesium supplementation
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo (Pla)
Number of subjects: 22
Study: 32268942

Group type: EXPERIMENTAL
Intervention: BP‐SES (biodegradable polymer sirolimus‐eluting stent)
Number of subjects: 440

Group type: COMPARATOR
Intervention: DP‐EES (durable polymer everolimus‐eluting stent)
Number of subjects: 440

Group type: EXPERIMENTAL
Intervention: BP‐SES
Number of subjects: 440

Group type: COMPARATOR
Intervention: DP‐EES
Number of subjects: 440
Study: 33407132

Group type: EXPERIMENTAL
Intervention: SSRs generated from RNA-sequencing analysis, with 96 pairs of primers selected for testing.
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Analysis of genetic diversity metrics based on SSRs.
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: NJ clustering and UPGMA/PCoA analysis.
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Analysis of molecular variance (AMOVA).
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Development of fingerprints for 79 Carex species.
Number of subjects: 79
Study: 33212488

Group type: EXPERIMENTAL
Intervention: Nivolumab plus ipilimumab
Number of subjects: 30
Study: 33260442

Group type: EXPERIMENTAL
Intervention: Children cared for by non-Latino providers
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Children with Latino providers
Number of subjects: 120
Study: 33378247

Group type: EXPERIMENTAL
Intervention: Intelligent personal assistants (IPAs) provided to individuals with ID
Number of subjects: 22
Study: 33622396

Group type: EXPERIMENTAL
Intervention: Pooled individual participant data (IPD) from randomised controlled trials (RCTs) conducted in adult care homes
Number of subjects: 418000

Group type: EXPERIMENTAL
Intervention: Pooled IPD
Number of subjects: 418000

Group type: EXPERIMENTAL
Intervention: Key resident characteristics and outcomes identified from trial repository
Number of subjects: 418000
Study: 32586100

Group type: EXPERIMENTAL
Intervention: Craniotomy-high H19 group
Number of subjects: 264

Group type: EXPERIMENTAL
Intervention: Craniotomy-low H19 group
Number of subjects: 264

Group type: COMPARATOR
Intervention: Endoscopic keyhole surgery (low H19)
Number of subjects: 264

Group type: COMPARATOR
Intervention: Endoscopic keyhole surgery (high H19)
Number of subjects: 264
Study: 35075671

Group type: EXPERIMENTAL
Intervention: Jump to Reference (J2R)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Copy Reference (CR)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Proposed reference-based imputation methods
Number of subjects: 0
Study: 33091585

Group type: EXPERIMENTAL
Intervention: Risk prediction algorithm combined with diagnostic testing (12-lead ECG and KardiaMobile device for home monitoring) for patients identified at highest risk (algorithm risk score ≥ 7.4%)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Routine management (Control)
Number of subjects: 0
Study: 33771903

Group type: EXPERIMENTAL
Intervention: 177Lu-DOTATATE
Number of subjects: 231

Group type: COMPARATOR
Intervention: high-dose octreotide LAR
Number of subjects: 231
Study: 32800482

Group type: EXPERIMENTAL
Intervention: Double faced tubularized preputial flap technique (group A)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Standard ventral preputial tubularized flap technique (group B)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Both groups (A and B)
Number of subjects: 160
Study: 34125503

Group type: EXPERIMENTAL
Intervention: HDx
Number of subjects: 43

Group type: COMPARATOR
Intervention: HDF
Number of subjects: 43
Study: 34630155

Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIT) for 12 weeks on a bicycle ergometer combined with strength training
Number of subjects: 86

Group type: COMPARATOR
Intervention: Moderate Continuous Training (MCT) for 12 weeks combined with strength training
Number of subjects: 86
Study: 36322510

Group type: EXPERIMENTAL
Intervention: Near-peer tutors
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Faculty tutors
Number of subjects: 32

Group type: COMPARATOR
Intervention: All tutors (near-peer and faculty)
Number of subjects: 32
Study: 32323462

Group type: EXPERIMENTAL
Intervention: Peeling with 70% glycolic acid followed by 5% 5-fluorouracil cream
Number of subjects: 17

Group type: COMPARATOR
Intervention: 5% 5-fluorouracil cream (twice daily)
Number of subjects: 17
Study: 35686572

Group type: EXPERIMENTAL
Intervention: V-01 vaccine
Number of subjects: 10218

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10218
Study: 34536716

Group type: EXPERIMENTAL
Intervention: Respecting the Circle of Life program (RCL)
Number of subjects: 534
Study: 32232708

Group type: EXPERIMENTAL
Intervention: MMC trabeculectomy with intracameral tPA
Number of subjects: 16

Group type: COMPARATOR
Intervention: MMC trabeculectomy
Number of subjects: 16
Study: 34247582

Group type: EXPERIMENTAL
Intervention: Physical exercises with elements of dance movement therapy (DMT), 30-min session, two times a week for 12 weeks
Number of subjects: 165

Group type: COMPARATOR
Intervention: Basic exercise (BE), 30-min session, two times a week for 12 weeks
Number of subjects: 165

Group type: COMPARATOR
Intervention: Usual care (CO)
Number of subjects: 165
Study: 36096844

Group type: EXPERIMENTAL
Intervention: Implementation of guidelines on Family Involvement
Number of subjects: 75
Study: 33952427

Group type: EXPERIMENTAL
Intervention: Bariatric surgery
Number of subjects: 0

Group type: COMPARATOR
Intervention: Community weight management intervention
Number of subjects: 0
Study: 35714630

Group type: EXPERIMENTAL
Intervention: Telemedicine specialty referral
Number of subjects: 1481

Group type: COMPARATOR
Intervention: Primary care referral
Number of subjects: 1481
Study: 33605029

Group type: EXPERIMENTAL
Intervention: Anakinra (100 or 200 mg/day for 5 days)
Number of subjects: 165

Group type: COMPARATOR
Intervention: Triamcinolone (40 mg in a single injection)
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Anakinra
Number of subjects: 165

Group type: COMPARATOR
Intervention: Triamcinolone
Number of subjects: 165
Study: 35949669

Group type: EXPERIMENTAL
Intervention: Transversus abdominis plane block (TAP)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Quadratus lumborum block (QL)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (no block)
Number of subjects: 80
Study: 34776136

Group type: EXPERIMENTAL
Intervention: Foam pad balance exercises (60 min/day, twice/week for 6 weeks)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Conventional therapy
Number of subjects: 30
Study: 32200815

Group type: EXPERIMENTAL
Intervention: I125 brachytherapy
Number of subjects: 638

Group type: COMPARATOR
Intervention: Control group (enucleation)
Number of subjects: 638
Study: 33974170

Group type: EXPERIMENTAL
Intervention: tDCS combined with conventional comprehensive treatment
Number of subjects: 40

Group type: COMPARATOR
Intervention: Conventional comprehensive treatment
Number of subjects: 40
Study: 34187533

Group type: EXPERIMENTAL
Intervention: Distributional approach for analysis of continuous outcomes
Number of subjects: 0

Group type: COMPARATOR
Intervention: Fisher's exact test
Number of subjects: 0

Group type: COMPARATOR
Intervention: 95% confidence interval for the difference in proportions
Number of subjects: 0
Study: 36006613

Group type: EXPERIMENTAL
Intervention: Therapeutic-dose bodyweight-adjusted oral rivaroxaban (n=40)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Standard anticoagulation with heparins, with or without vitamin K antagonists (n=16)
Number of subjects: 56
Study: 34275343

Group type: EXPERIMENTAL
Intervention: Virtual Reality (VR) device
Number of subjects: 106

Group type: COMPARATOR
Intervention: iPad group
Number of subjects: 106
Study: 32859177

Group type: EXPERIMENTAL
Intervention: Stepped care model
Number of subjects: 737
Study: 35095084

Group type: EXPERIMENTAL
Intervention: Initial combination therapy with ambrisentan and tadalafil
Number of subjects: 302
Study: 36283254

Group type: EXPERIMENTAL
Intervention: Pingchan granule (PCG)
Number of subjects: 292

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 292
Study: 35265707

Group type: EXPERIMENTAL
Intervention: Cognitive behavioural self-help intervention
Number of subjects: 77

Group type: COMPARATOR
Intervention: Wait-list condition
Number of subjects: 77
Study: 32314466

Group type: EXPERIMENTAL
Intervention: Regimen A (emollient-containing diaper with acidic, pH-buffered wipe)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Regimen B (non-emollient diaper and wipe with limited buffering capacity)
Number of subjects: 0
Study: 35575751

Group type: COMPARATOR
Intervention: Sensor-augmented pump therapy
Number of subjects: 0
Study: 33743017

Group type: EXPERIMENTAL
Intervention: Radiomics model based on relaxation maps
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Radiomics nomogram
Number of subjects: 94

Group type: COMPARATOR
Intervention: Radiomics signature
Number of subjects: 94
Study: 33186396

Group type: EXPERIMENTAL
Intervention: exercise (participants anticipated and completed exercise)
Number of subjects: 31

Group type: COMPARATOR
Intervention: anticipation (participants anticipated exercise but completed rest)
Number of subjects: 31

Group type: COMPARATOR
Intervention: rest (participants anticipated and completed rest)
Number of subjects: 31
Study: 34542654

Group type: EXPERIMENTAL
Intervention: Infection of retropharyngeal, pretracheal and carotid space, C-reactive protein and procalcitonin values
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: Multispace neck infection
Number of subjects: 141
Study: 32034016

Group type: EXPERIMENTAL
Intervention: 30 mg orvepitant
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: 10 mg orvepitant
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study: 32169030

Group type: EXPERIMENTAL
Intervention: Mindfulness-based intervention (MBI)
Number of subjects: 206

Group type: COMPARATOR
Intervention: Care as usual (control group)
Number of subjects: 206
Study: 35290819

Group type: EXPERIMENTAL
Intervention: Emotional reactivity
Number of subjects: 172

Group type: EXPERIMENTAL
Intervention: Emotion regulation
Number of subjects: 172

Group type: EXPERIMENTAL
Intervention: Subsample analysis with anxiety disorder
Number of subjects: 172

Group type: EXPERIMENTAL
Intervention: Subsample analysis without anxiety disorder
Number of subjects: 172
Study: 33957767

Group type: EXPERIMENTAL
Intervention: Tufts Be Well at Work
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study: 32552782

Group type: EXPERIMENTAL
Intervention: Low-pressure pneumoperitoneum (8 mmHg) facilitated by deep neuromuscular blockade (post tetanic count of 1-2)
Number of subjects: 204

Group type: COMPARATOR
Intervention: Normal-pressure pneumoperitoneum (12 mmHg) with moderate neuromuscular blockade (train-of-four response of 1-2)
Number of subjects: 204
Study: 34704120

Group type: EXPERIMENTAL
Intervention: Non-severe hypoglycaemic episodes (NSHEs) 2-11 per year
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Non-severe hypoglycaemic episodes (NSHEs) ≥12 per year
Number of subjects: 0
Study: 34635141

Group type: EXPERIMENTAL
Intervention: Kinect-based Rapid Movement Training (RMT)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Conventional Balance Training (CBT)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Both groups (RMT and CBT)
Number of subjects: 30
Study: 33030753

Group type: EXPERIMENTAL
Intervention: Reducing drinking (AUDIT < 8)
Number of subjects: 2003
Study: 36108603

Group type: EXPERIMENTAL
Intervention: Topical anesthesia prior to mydriatic drops
Number of subjects: 66

Group type: COMPARATOR
Intervention: Preservative-free artificial tear drops (Control)
Number of subjects: 66
Study: 32138790

Group type: EXPERIMENTAL
Intervention: Ovarian hyperstimulation syndrome (OHSS)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Advanced ovarian cancer (OC)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Benign adnexal mass (BAM)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Ovarian endometriosis (EM)
Number of subjects: 76
Study: 32957816

Group type: EXPERIMENTAL
Intervention: Preeclampsia group (8 women)
Number of subjects: 136

Group type: COMPARATOR
Intervention: Control group (8 normotensive women)
Number of subjects: 136
Study: 34606529

Group type: EXPERIMENTAL
Intervention: Exogenous ketone supplement (β‐hydroxybutyrate)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 35943847

Group type: EXPERIMENTAL
Intervention: Zentangle group (2-hr class and encouraged practice for 2 weeks)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Zentangle practice for >80 min per week
Number of subjects: 38

Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 38
Study: 33616836

Group type: EXPERIMENTAL
Intervention: Risk prediction model for permanent congenital hypothyroidism (CH)
Number of subjects: 1047
Study: 32664535

Group type: EXPERIMENTAL
Intervention: HVLA plus resistance exercise
Number of subjects: 31

Group type: COMPARATOR
Intervention: Resistance exercise alone
Number of subjects: 31
Study: 35686380

Group type: EXPERIMENTAL
Intervention: Celecoxib-tramadol co-crystal (CTC) 200 mg every 12 h
Number of subjects: 637

Group type: EXPERIMENTAL
Intervention: Tramadol 50 mg every 6 h
Number of subjects: 637

Group type: EXPERIMENTAL
Intervention: Celecoxib 100 mg every 12 h
Number of subjects: 637

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 637
Study: 33605620

Group type: EXPERIMENTAL
Intervention: Nebulized amikacin at a dose of 40 mg/kg/day for 3-5 days
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nebulized colistimethate sodium (CMS) at a dose of 15 million IU/day for 3-5 days
Number of subjects: 0

Group type: COMPARATOR
Intervention: Intravenous administration of a new cephalosporine/ß-lactamase inhibitor for 7 days
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nebulized CMS at a dose of 15 million IU/day for VAP caused by pandrug-resistant GNB
Number of subjects: 0

Group type: COMPARATOR
Intervention: Intravenous CMS at a dose of 9 million IU/day
Number of subjects: 0
Study: 32741773

Group type: EXPERIMENTAL
Intervention: 400 mg/day ubiquinol from 7 days before to 5 days after surgery
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 34888277

Group type: EXPERIMENTAL
Intervention: Community-wide mass drug administration (cMDA) for soil-transmitted helminths (STH) delivered by CDDs.
Number of subjects: 104
Study: 32712307

Group type: EXPERIMENTAL
Intervention: 38% silver diamine fluoride (SDF) solution
Number of subjects: 194

Group type: COMPARATOR
Intervention: Tonic water (control)
Number of subjects: 194
Study: 36483117

Group type: EXPERIMENTAL
Intervention: WW + PolyRules!
Number of subjects: 30

Group type: COMPARATOR
Intervention: WW
Number of subjects: 30
Study: 32253540

Group type: EXPERIMENTAL
Intervention: Universal school-based mental health program combining mental health literacy and dialectical behavior skills
Number of subjects: 113

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 113
Study: 34520520

Group type: EXPERIMENTAL
Intervention: Intrathecal morphine (5 mcg/kg)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Intrathecal saline (placebo)
Number of subjects: 79
Study: 34666202

Group type: EXPERIMENTAL
Intervention: Yogurt (220 g/d)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Milk (220 g/d)
Number of subjects: 92
Study: 33711262

Group type: EXPERIMENTAL
Intervention: SARS-CoV-2 prevalence (combined measure)
Number of subjects: 4258

Group type: EXPERIMENTAL
Intervention: rtPCR-positive prevalence
Number of subjects: 4258

Group type: EXPERIMENTAL
Intervention: ELISA-positive prevalence
Number of subjects: 4258

Group type: EXPERIMENTAL
Intervention: Estimated number of SARS-CoV-2 infections
Number of subjects: 4258
Study: 32129141

Group type: EXPERIMENTAL
Intervention: Single dose of GO-ON (5 mL)
Number of subjects: 127

Group type: COMPARATOR
Intervention: Three repeated doses of GO-ON (2.5 mL each)
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Cost of single-dose injection
Number of subjects: 127
Study: 36244014

Group type: EXPERIMENTAL
Intervention: Retrograde intrarenal surgery (RIRS)
Number of subjects: 90

Group type: COMPARATOR
Intervention: mini-percutaneous nephrolithotomy (mini-PCNL)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Both RIRS and mini-PCNL
Number of subjects: 90
Study: 33832352

Group type: EXPERIMENTAL
Intervention: Dapagliflozin
Number of subjects: 4744

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4744
Study: 36085065

Group type: EXPERIMENTAL
Intervention: Guided meditation for 6 weeks
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (no guided meditation)
Number of subjects: 80
Study: 36255339

Group type: EXPERIMENTAL
Intervention: Spiritual Care (SC) for 3 days
Number of subjects: 145

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 145
Study: 34636210

Group type: EXPERIMENTAL
Intervention: Distal-triangular flap
Number of subjects: 60

Group type: COMPARATOR
Intervention: Szmyd flap
Number of subjects: 60

Group type: COMPARATOR
Intervention: Envelope flap
Number of subjects: 60
Study: 35511258

Group type: EXPERIMENTAL
Intervention: Simvastatin (N = 27)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Placebo (N = 26)
Number of subjects: 53
Study: 33762075

Group type: EXPERIMENTAL
Intervention: 6Pa200MZ
Number of subjects: 203

Group type: EXPERIMENTAL
Intervention: 4Pa200MZ
Number of subjects: 203

Group type: EXPERIMENTAL
Intervention: 4Pa100MZ
Number of subjects: 203

Group type: COMPARATOR
Intervention: Control
Number of subjects: 203

Group type: EXPERIMENTAL
Intervention: Experimental regimens
Number of subjects: 203
Study: 35394987

Group type: EXPERIMENTAL
Intervention: Text messaging intervention
Number of subjects: 824
Study: 33201535

Group type: EXPERIMENTAL
Intervention: 0.1, 0.2, or 0.3 mg/kg bumetanide
Number of subjects: 43

Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 43
Study: 35694704

Group type: EXPERIMENTAL
Intervention: MRI examination (group B)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Arthroscopy (group A)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: SMASH algorithm
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Traditional SOS algorithm
Number of subjects: 96
Study: 34346136

Group type: EXPERIMENTAL
Intervention: Endometrial scratching
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 35272940

Group type: EXPERIMENTAL
Intervention: Vasopressin injection during ovarian cystectomy
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (no vasopressin injection)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Both groups (vasopressin and control)
Number of subjects: 120
Study: 32310706

Group type: EXPERIMENTAL
Intervention: Best-Corrected Visual Acuity (BCVA)
Number of subjects: 2018

Group type: EXPERIMENTAL
Intervention: Presenting Visual Acuity (PVA)
Number of subjects: 2018

Group type: EXPERIMENTAL
Intervention: Age and Central Corneal Thickness
Number of subjects: 2018

Group type: EXPERIMENTAL
Intervention: Causes of impaired BCVA
Number of subjects: 2018